Advancements in the treatment of osteochondral lesions of the talus

Abstract Osteochondral lesions of the talus (OLT) are common ankle joint pathologies, often caused by traumatic or non-traumatic factors. Due to the anatomical characteristics and limited blood supply of the talus, the spontaneous healing capacity of OLT is poor, posing challenges for clinical treat...

Full description

Saved in:
Bibliographic Details
Main Authors: Lianjie Cheng, Xuena Wang
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:https://doi.org/10.1186/s13018-024-05314-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849220663084056576
author Lianjie Cheng
Xuena Wang
author_facet Lianjie Cheng
Xuena Wang
author_sort Lianjie Cheng
collection DOAJ
description Abstract Osteochondral lesions of the talus (OLT) are common ankle joint pathologies, often caused by traumatic or non-traumatic factors. Due to the anatomical characteristics and limited blood supply of the talus, the spontaneous healing capacity of OLT is poor, posing challenges for clinical treatment. Traditional treatments include conservative therapy and surgical interventions, but their efficacy is limited. In recent years, significant advancements in OLT treatment have been achieved with developments in biomaterials science, cell biology, and tissue engineering. This article summarizes the latest research progress in various treatment methods, including conservative treatment, bone marrow stimulation, chondrocyte transplantation, and osteochondral grafting, and evaluates the role of biological augmentation agents such as platelet-rich plasma (PRP) and concentrated bone marrow aspirate (CBMA) in promoting cartilage repair. Additionally, the application of biological scaffold technology offers new prospects for cartilage regeneration. Although emerging therapies show potential in clinical practice, further research is needed to evaluate their long-term efficacy, indications, and safety. This article aims to provide valuable references for clinicians, researchers, and policymakers, promoting the development and refinement of OLT treatment strategies.
format Article
id doaj-art-81d7e4d70caf48c1a064ce5fc8ce7f1d
institution Kabale University
issn 1749-799X
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj-art-81d7e4d70caf48c1a064ce5fc8ce7f1d2024-12-08T12:37:53ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2024-12-011911910.1186/s13018-024-05314-6Advancements in the treatment of osteochondral lesions of the talusLianjie Cheng0Xuena Wang1Department of Hand & Foot and Reconstructive Microsurgery, Shandong Provincial Hospital, Shandong First Medical UniversityDepartment of Nephropathy and Rheumatology, Shandong Provincial Third Hospital, Shandong UniversityAbstract Osteochondral lesions of the talus (OLT) are common ankle joint pathologies, often caused by traumatic or non-traumatic factors. Due to the anatomical characteristics and limited blood supply of the talus, the spontaneous healing capacity of OLT is poor, posing challenges for clinical treatment. Traditional treatments include conservative therapy and surgical interventions, but their efficacy is limited. In recent years, significant advancements in OLT treatment have been achieved with developments in biomaterials science, cell biology, and tissue engineering. This article summarizes the latest research progress in various treatment methods, including conservative treatment, bone marrow stimulation, chondrocyte transplantation, and osteochondral grafting, and evaluates the role of biological augmentation agents such as platelet-rich plasma (PRP) and concentrated bone marrow aspirate (CBMA) in promoting cartilage repair. Additionally, the application of biological scaffold technology offers new prospects for cartilage regeneration. Although emerging therapies show potential in clinical practice, further research is needed to evaluate their long-term efficacy, indications, and safety. This article aims to provide valuable references for clinicians, researchers, and policymakers, promoting the development and refinement of OLT treatment strategies.https://doi.org/10.1186/s13018-024-05314-6Osteochondral lesionsBone marrow stimulationChondrocyte transplantationOsteochondral graftingBiological augmentation agents
spellingShingle Lianjie Cheng
Xuena Wang
Advancements in the treatment of osteochondral lesions of the talus
Journal of Orthopaedic Surgery and Research
Osteochondral lesions
Bone marrow stimulation
Chondrocyte transplantation
Osteochondral grafting
Biological augmentation agents
title Advancements in the treatment of osteochondral lesions of the talus
title_full Advancements in the treatment of osteochondral lesions of the talus
title_fullStr Advancements in the treatment of osteochondral lesions of the talus
title_full_unstemmed Advancements in the treatment of osteochondral lesions of the talus
title_short Advancements in the treatment of osteochondral lesions of the talus
title_sort advancements in the treatment of osteochondral lesions of the talus
topic Osteochondral lesions
Bone marrow stimulation
Chondrocyte transplantation
Osteochondral grafting
Biological augmentation agents
url https://doi.org/10.1186/s13018-024-05314-6
work_keys_str_mv AT lianjiecheng advancementsinthetreatmentofosteochondrallesionsofthetalus
AT xuenawang advancementsinthetreatmentofosteochondrallesionsofthetalus